Studies how the body handles standard drugs given to children with leukemia
Observes how children with acute lymphoblastic leukemia process their usual prescribed medicines.
Key facts
- Who runs it
- Duke University
- Where
- Durham, United StatesSee the site
- Trial code
- Registry title
- Pharmacokinetics of Drugs Administered to Children
- Status
- Recruiting
- People taking part
- 200 people, planned
- Started
- 14 Aug 2013
- Expected to end
- 14 Aug 2033
- Type of study
- Observational
- Treatments tested
- Standard of care drug
- Record updated
- 7 January 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children and young people under 21 who are already receiving certain drugs as part of their normal care. It studies how the body handles those drugs.
- Age
- Under 21 years (0 to 20 years)
- Sex
- All sexes can join.
- Earlier treatment
- They must be receiving drugs of interest as part of standard care, as prescribed by their treating caregiver.
Main reasons for not taking part
- Consent or assent not obtained (as indicated)
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Children (< 21 years of age) who are receiving understudied drugs of interest per standard of care as prescribed by their treating caregiver
Who cannot take part
- Failure to obtain consent/assent (as indicated)
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 0 and 20 years old?
Where in United States
- Duke UniversityDurham, United StatesContact: Rachel Greenberg, MDTaking people
About the trial
What the trial wants to find out
This is a prospective study of children <21 years of age with the goal of characterizing the PK of drugs administered per standard of care as prescribed by the treating caregiver.
Treatments tested
- Standard of care drug
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Pharmacokinetics of Drugs Administered to Children Per Standard of Care
- Plain-language title
- Studies how the body handles standard drugs given to children with leukemiaGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT03481881, who can take part
- Record updated
- 7 January 2026